Drug Trial Radar · NCT07089043
A Study in Subjects With Neurogenic Orthostatic Hypotension
Last checked: Nov 19, 2026Latest source record: Oct 22, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
12
Actual
Start
Sep 12, 2025
Primary completion
Sep 24, 2026
Study completion Oct 2026
Sponsor
- Lead sponsor
- CuraSen Therapeutics, Inc.Industry
- Sponsor type
- Industry
- First posted
- Jul 28, 2025
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Non randomized
- Model
- Sequential
- Masking
- Single (participant)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 85 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a study to evaluate the effects of CST-3056 on orthostatic symptoms and signs in subjects with neurogenic orthostatic hypotension (nOH).
Conditions
- Neurogenic Orthostatic Hypotension
Interventions
CST-3056Drug
Administered as an oral solution
PlaceboDrug
Administered as an oral solution
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change from Baseline in Standing Systolic Blood PressureTime frame: Baseline and 1, 2, 3, and 4 hours post-dose on Days 1 to 4
Locations
5 sites in 1 country. Site status is shown where the registry gives one.
CuraSen Investigational Site
Scottsdale, Arizona
CuraSen Investigational Site
Farmington Hills, Michigan
CuraSen Investigational Site
Eatontown, New Jersey
CuraSen Investigational Site
New York, New York
CuraSen Investigational Site
Nashville, Tennessee
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.